Information on EC 2.4.1.16 - chitin synthase

Word Map on EC 2.4.1.16
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Specify your search results
Select one or more organisms in this record:
Show additional data
Do not include text mining results
Include (text mining) results (more...)
Include results (AMENDA + additional results, but less precise; more...)

The enzyme appears in viruses and cellular organisms

EC NUMBER
COMMENTARY hide
2.4.1.16
-
RECOMMENDED NAME
GeneOntology No.
chitin synthase
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
UDP-N-acetyl-alpha-D-glucosamine + [4)-N-acetyl-beta-D-glucosaminyl-(1->]n = UDP + [4)-N-acetyl-beta-D-glucosaminyl-(1->]n+1
show the reaction diagram
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
hexosyl group transfer
-
-
-
-
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
Amino sugar and nucleotide sugar metabolism
-
-
chitin biosynthesis
-
-
SYSTEMATIC NAME
IUBMB Comments
UDP-N-acetyl-D-glucosamine:chitin 4-beta-N-acetylglucosaminyltransferase
Converts UDP-N-acetyl-alpha-D-glucosamine into chitin and UDP.
CAS REGISTRY NUMBER
COMMENTARY hide
9030-18-6
-
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
IM-80
-
-
Manually annotated by BRENDA team
Apodachlya sp.
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
UniProt
Manually annotated by BRENDA team
a haploid strain, gene BcChs6 or BC1G_15936.1
UniProt
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
Chlorovirus CVK2
-
-
-
Manually annotated by BRENDA team
-
Uniprot
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
EhCHS-1; EhCHS-2
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
isoform CHS1
-
-
Manually annotated by BRENDA team
strain GZ03643
-
-
Manually annotated by BRENDA team
strain GZ03643
-
-
Manually annotated by BRENDA team
chitin synthase 2; f. sp. lycopersici, myosin motor-like chitin synthase gene chsVb
UniProt
Manually annotated by BRENDA team
Kluyveromyces bulgaricus
ATCC 96631
-
-
Manually annotated by BRENDA team
LeChs1; an edible basidiomycetous mushroom, strain strain SB1226, gene Lechs1, isozyme LeChs1
UniProt
Manually annotated by BRENDA team
Lucilia sp.
-
-
-
Manually annotated by BRENDA team
isoform Chs7; isoform CHS7
UniProt
Manually annotated by BRENDA team
Mortierella candelabrum
-
-
-
Manually annotated by BRENDA team
Mortierella pusilla
-
-
-
Manually annotated by BRENDA team
isolate PHI26, gene chsVII
UniProt
Manually annotated by BRENDA team
isolate PHI26, gene chsVII
UniProt
Manually annotated by BRENDA team
an edible basidiomycetous mushroom, class IV chitin synthase isozyme, gene Pochs1
-
-
Manually annotated by BRENDA team
X2180 strains
-
-
Manually annotated by BRENDA team
strain Y3437, isozyme Chs2
UniProt
Manually annotated by BRENDA team
strain YPH499 and ECY38-38A, isozyme CHS2p encoded by gene CHS2; strain YPH499 and ECY38-38A, isozymes CHS1p and CHS3p encoded by genes CHS1 and CHS3
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
4 isozymes, CHS1-CHS4
-
-
Manually annotated by BRENDA team
4 isozymes, CHS1-CHS4
-
-
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
evolution
malfunction
metabolism
-
chitin production in arthropods is a complicated process and a series of biochemical pathways are involved in individual chitin polymer biosynthesis in which the terminal step is catalyzed by chitin synthase
physiological function
additional information
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
6-O-dansyl-N-acetylglucosamine + [1,4-(N-acetyl-beta-D-glucosaminyl)]n
?
show the reaction diagram
Kluyveromyces bulgaricus
-
-
-
-
?
acetyl-D-glucosamine + [1,4-(N-acetyl-beta-D-glucosaminyl)]n
UDP + [1,4-(N-acetyl-beta-D-glucosaminyl)]n+1
show the reaction diagram
Kluyveromyces bulgaricus
-
-
-
-
?
chitobiose + N-acetyl-D-glucosamine
UDP + 1,4-(N-acetyl-beta-D-glucosaminyl)x
show the reaction diagram
-
-
-
-
?
UDP-GlcNAc + GlcNAc
UDP + N-acetyl-beta-D-glucosaminyl-(1,4)-N-acetyl-beta-D-glucosamine
show the reaction diagram
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + [1,4-(N-acetyl-beta-D-glucosaminyl)]n
UDP + [1,4-(N-acetyl-beta-D-glucosaminyl)]n+1
show the reaction diagram
UDP-N-acetyl-D-glucosamine + N-acetyl-D-glucosamine
UDP + 1,4-(N-acetyl-beta-D-glucosaminyl)2
show the reaction diagram
-
-
-
-
?
UDP-N-acetyl-D-glucosamine + [(1-4)-N-acetyl-beta-D-glucosaminyl-]n
UDP + [(1-4)-N-acetyl-beta-D-glucosaminyl-]n+1
show the reaction diagram
UDP-N-acetyl-D-glucosamine + [1,4-(N-acetyl-beta-D-glucosaminyl)]n
UDP + [1,4-(N-acetyl-beta-D-glucosaminyl)]n+1
show the reaction diagram
UDP-N-acetyl-D-glucosamine + [4-N-acetyl-beta-D-glucosaminyl-(1-)]n
UDP + [4-N-acetyl-beta-D-glucosaminyl-(1-)]n+1
show the reaction diagram
additional information
?
-
NATURAL SUBSTRATES
NATURAL PRODUCTS
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
UDP-N-acetyl-alpha-D-glucosamine + [1,4-(N-acetyl-beta-D-glucosaminyl)]n
UDP + [1,4-(N-acetyl-beta-D-glucosaminyl)]n+1
show the reaction diagram
UDP-N-acetyl-D-glucosamine + [1,4-(N-acetyl-beta-D-glucosaminyl)]n
UDP + [1,4-(N-acetyl-beta-D-glucosaminyl)]n+1
show the reaction diagram
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
INHIBITORS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(2R,3R,4R,5R)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
-
IC50: 1.6 mM
(2R,3R,4R,5S)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
-
IC50: 38 mM
(2S,3R,4R,5R)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
-
IC50: 4.0 mM
1-(2,2-dibutyl-5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-3(2H)-yl)ethanone
-
0.25 mM, about 30% residual activity
1-Geranyl-2-methylbenzimidazole
-
weak
1-[2,2-dibutyl-5-(2-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 10% residual activity
1-[2,2-dibutyl-5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 30% residual activity
1-[2,2-dibutyl-N-[(2,6-difluorophenyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 20% residual activity
1-[2,2-dibutyl-N-[(2-chlorophenyl)carbonyl]-5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 15% residual activity
1-[2,2-dibutyl-N-[(2-chlorophenyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 25% residual activity
2,2'-methylenebis(3,4,6-trichlorophenol)
-
0.25 mM, 56% inhibition
2,3,5,6-Tetrachloro-4-methoxyphenol
-
0.25 mM, 48% inhibition
2,5-dideoxy-2,5-imino-D-glucitol
-
IC50: 5.7 mM
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N,N-dipropylacetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(2-nitrophenyl)acetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(3-nitrophenyl)acetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(4-(trifluoromethyl)phenyl)acetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(4-methoxyphenyl)acetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(4-nitrophenyl)acetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(ptolyl)acetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-methyl-N-phenylacetamide
-
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-phenylacetamide
-
-
-
3,5-Dichloro-4-methoxybenzaldehyde
-
0.25 mM, 17% inhibition
3,5-Dichloro-4-methoxybenzyl alcohol
-
0.25 mM, 40% inhibition
3,5-Dichlorobenzyl alcohol
-
0.25 mM, 15% inhibition
3-(2-hydroxy-3-(methyl(2-oxo-2-(piperidin-1-yl)ethyl)amino)propyl)-1-methylquinazoline-2,4(1H,3H)-dione
-
-
-
5'-(N-succinyl)-5'-amino-5'-deoxyuridine
-
-
-
5'-(N-succinyl)-5'-amino-5'-deoxyuridine methyl ester
-
inhibits the yeast enzyme, and exhibits synergistic interaction with caspofungin against Candida albicans
-
5'-(N-succinylglycyl)-5'-amino-5'-deoxyuridine
-
-
-
5'-(N-succinylglycyl)-5'-amino-5'-deoxyuridine methyl ester
-
-
-
5'-deoxy-5'-(glycylamino)uridine
-
-
-
8,20-dihydroxy-9(11),13-abietadien-12-one
AMP
-
6.25 mM
amphotericin
-
noncompetitive
Amphotericin B methyl ester
-
-
Ba2+
-
10 mM, 61% inhibition
bis(5'-amino-5'-deoxyuridine) 2,2'-[(1,4-dioxobutane-1,4-diyl)diazanediyl]diacetate
-
50% inhibition at 3 mM
-
bis(5'-amino-5'-deoxyuridine) 4-[(carboxymethyl)amino]-4-oxobutanoate
-
-
-
bis(5'-amino-5'-deoxyuridine) succinate
-
-
-
c3',5'-AMP
-
2 mM, slight inhibition
Calcofluor white
-
noncompetitive
Captan
Cd2+
complete inhibition of wild-type and mutant enzymes
chitin oligosaccharides
-
slight
chitodextrins
-
-
-
Cl-
-
10 mM
Diflubenzuron
edifenphos
-
non-competitive
Filipin
-
weak
Hexachlorophene
-
inhibition can be reversed by lecithin
insecticidal benzoylphenyl ureas
-
-
-
K+
-
10 mM, 14% inhibition
kanakugiol
-
inhibition of chitin synthase 2 and antifungal activity of the lignan from the stem bark of Lindera erythrocarpa, overview
linderone
-
inhibition of chitin synthase 2 and antifungal activity of the lignan from the stem bark of Lindera erythrocarpa, overview
methyl 2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy) (phenoxy)phosphorylamino)-3-phenylpropanoate}
-
-
-
methyl 2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy) (phenoxy)phosphorylamino)acetate}
-
-
-
methyl 2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate}
-
-
-
methyl 2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate}
-
-
-
methyl 2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)acetate}
-
-
-
methyl 2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate}
-
-
-
methyl 2-((2-(methyl(6-tert-buty-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
-
a noncompetitive inhibitor against chitin synthase
-
methyl 2-((2-(methyl(6-tert-buty-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)acetate}
-
-
-
methyl 2-((2-(methyl(6-tert-buty-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate}
-
-
-
methyl 2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate}
-
-
-
methyl 2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-acetate}
-
-
-
methyl 2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate}
-
-
-
methyl 2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate}
-
-
-
methyl 2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-acetate}
-
-
-
methyl 2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate}
-
-
-
methyl 2-(2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamido)benzoate
-
-
-
methyl 3-methyl-2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate}
-
-
-
methyl 3-methyl-2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate}
-
-
-
methyl 3-methyl-2-((2-(methyl(6-tert-buty-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate}
-
-
-
methyl 3-methyl-2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate}
-
-
-
methyl 3-methyl-2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate}
-
-
-
methyllinderone
-
inhibition of chitin synthase 2 and antifungal activity of the lignan from the stem bark of Lindera erythrocarpa, overview
N,N-dibenzyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl) (methyl) amino)acetamide
-
-
-
N,N-diethyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl) (methyl) amino)acetamide
-
-
-
N- benzyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl) amino)acetamide
-
-
-
N-(2-chlorophenyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
-
N-(4-(cyanomethyl)phenyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
-
N-(4-chlorobenzyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
-
N-(4-chlorophenyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
-
N-(tert-butyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl) amino)acetamide
-
-
-
N-acetyl-D-glucosamine-N,N-diacetylchitobiose
-
-
-
NaCl
-
0.5 M, 86% inhibition of Chs1 and 29% inhibition of Chs2
Nikkomycin
nikkomycin X
-
-
nikkomycin Z
Nystatin
-
-
O-methyl pisiferic acid
oudemansin B
-
0.25 mM, 31% inhibition
Pentachlorophenol
-
0.25 mM, 67% inhibition
Polyoxin B
Polyoxin D
polyoxin L
Primulin
-
noncompetitive
SO42-
-
10 mM
strobilurin A
-
0.25 mM, 24% inhibition
strobilurin B
-
0.25 mM, 29% inhibition
terpenoyl benzimidazole
-
weak
UDPgalacturonic acid
-
1 mM, about 20% inhibition
UDPglucose
-
1 mM, about 20% inhibition
UDPglucuronic acid
-
1 mM, about 20% inhibition
UDPmannose
-
1 mM, about 20% inhibition
UDPxylose
-
1 mM, about 20% inhibition
UMP
-
6.25 mM
uracil polyoxin C methyl ester
[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamic acid 2-[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethylcarbamoyloxy]-ethyl ester
-
1 mM, 32% inhibition, competitive. IC50: 2.2 mM
[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamic acid 2-{2-[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethylcarbamoyloxy]-ethoxy}-ethyl ester
-
1 mM 45% inhibition. IC50: 11.8 mM
additional information
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
chitodextrin F1
-
5 mg/ml, 183% increase in activity
-
chitodextrin F2
-
5 mg/ml, 170% increase in activity
-
diacetylchitobiose
-
activates
Digitonin
GlcNAc
glucose
lysophosphatidylserine
-
required, phosphatidylserine and lysophosphatidylserine are the best activators
N-acetyl-alpha-D-glucosamine
-
stimulates CHS activity at 2.5 mM but inhibits enzyme activity at higher concentrations
N-acetyl-D-glucosamine
GlcNAc and 2-acylamido analogues of GlcNAc stimulate formation of chitin oligosaccharides by yeast chitin synthase, and GlcNAc is transferred to the 2-acylamido analogues. Synthesis of chitin oligosaccharides is strongly dependent on inclusion of GlcNAc in chitin synthase incubations. Formation of both chitin oligosaccharides and insoluble chitin is also stimulated by GlcNAc2
N-butanoyl-D-glucosamine
stimulates formation of both chitin oligosaccharides and insoluble chitin from the 2-acylamido analogues of UDP-N-acetyl-alpha-D-glucosamine
N-Glycolyl-D-glucosamine
stimulates formation of both chitin oligosaccharides and insoluble chitin from the 2-acylamido analogues of UDP-N-acetyl-alpha-D-glucosamine
N-propanoyl-D-glucosamine
stimulates formation of both chitin oligosaccharides and insoluble chitin from the 2-acylamido analogues of UDP-N-acetyl-alpha-D-glucosamine
-
Nystatin
-
0.05 mM, marked stimulation
papain
-
fairly good activator of Chs1, poor activator of Chs2
-
phosphatidylethanolamine
-
stimulates
phosphatidylinositol
-
stimulates
phosphatidylserine
Phospholipid
-
required, phosphatidylserine and lysophosphatidylserine are the best activators
Pronase
-
stimulates both Chs1 and Chs2
-
proteinase B
-
from Saccharomyces cerevisiae, stimulates Chs1, no effect on Chs2
-
proteinase K
-
stimulates both Chs1 and Chs2
-
Staphylococcus V8 protease
-
best activator of Chs2 in presence of Co2+, elicits little Mg2+-stimulatable activity
-
Trypsin
Apodachlya sp.
-
activates
-
UDP-N-acetyl-alpha-D-glucosamine
-
-
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.5
6-O-dansyl N-acetylglucosamine
Kluyveromyces bulgaricus
-
chitin synthetase II
0.0133 - 0.2
6-O-dansyl-N-acetylglucosamine
2.3
chitobiose
-
-
3.1
N-acetyl-D-glucosamine
-
reaction with UDP-N-acetyl-D-glucosamine
0.5 - 2.5
UDP-GlcNAc
3.86
UDP-N-acetyl-alpha-D-glucosamine
-
pH 7.5, 37°C
2.6
UDP-N-acetyl-D-glucosamine
-
reaction with chitobiose
1.5 - 3.1
UDP-N-acetylglucosamine
additional information
additional information
-
Michaelis-Menten kinetics
-
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0009
5-((2-amino-5-O-(aminocarbonyl)-2-deoxy-L-xylonoyl)amino)-1-(5-carboxy-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,5-dideoxy-beta-D-allofuranuronic acid
-
chitin synthetase 1
0.13
Amphotericin B
-
-
0.054
edifenphos
-
-
0.0085
Hexachlorophene
-
-
0.096
methyl 2-((2-(methyl(6-tert-buty-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
-
pH 7.5, 37°C
-
0.002
Nikkomycin
-
-
0.00014
nikkomycin X
-
chitin synthetase 1
0.0001 - 0.0068
nikkomycin Z
0.005
O-methyl pisiferic acid
versus UDP-N-acetyl-beta-D-glucosamine; versus UDP-N-acetyl-beta-D-glucosamine
0.00065
polyoxin
-
-
-
0.032
Polyoxin B
-
-
0.001 - 2.5
Polyoxin D
0.014
Primulin
-
-
0.19 - 2.2
UDP
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1.6
(2R,3R,4R,5R)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
Saccharomyces cerevisiae
-
IC50: 1.6 mM
38
(2R,3R,4R,5S)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
Saccharomyces cerevisiae
-
IC50: 38 mM
4
(2S,3R,4R,5R)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
Saccharomyces cerevisiae
-
IC50: 4.0 mM
0.0079
1-[2,2-dibutyl-5-(2-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
Saccharomyces cerevisiae
-
-
0.0056
1-[2,2-dibutyl-N-[(2-chlorophenyl)carbonyl]-5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
Saccharomyces cerevisiae
-
-
5.7
2,5-dideoxy-2,5-imino-D-glucitol
Saccharomyces cerevisiae
-
IC50: 5.7 mM
0.8
5'-(N-succinyl)-5'-amino-5'-deoxyuridine methyl ester
Saccharomyces cerevisiae
-
pH 7.5, 25°C
-
0.171 - 0.44
8,20-dihydroxy-9(11),13-abietadien-12-one
0.0238
kanakugiol
Saccharomyces cerevisiae
-
-
0.0214
linderone
Saccharomyces cerevisiae
-
-
0.08
methyl 2-((2-(methyl(6-tert-buty-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
Candida tropicalis
-
pH 7.5, 37°C
-
0.0233
methyllinderone
Saccharomyces cerevisiae
-
-
0.0011 - 0.355
neopolyoxin C
0.022 - 0.032
Nikkomycin
0.0058 - 0.424
O-methyl pisiferic acid
0.16 - 0.18
Polyoxin B
0.0059 - 0.0886
Polyoxin D
2.2
[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamic acid 2-[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethylcarbamoyloxy]-ethyl ester
Saccharomyces cerevisiae
-
1 mM, 32% inhibition, competitive. IC50: 2.2 mM
11.8
[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamic acid 2-{2-[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethylcarbamoyloxy]-ethoxy}-ethyl ester
Saccharomyces cerevisiae
-
1 mM 45% inhibition. IC50: 11.8 mM
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0.0025
Kluyveromyces bulgaricus
-
chitin synthetase III, activity at the end of exponential growth phase
0.0028
Kluyveromyces bulgaricus
-
chitin synthetase II, activity at the end of exponential growth phase
0.0055
-
-
0.008
Kluyveromyces bulgaricus
-
chitin synthetase I, activity at the end of exponential growth phase
additional information
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
5.8 - 6.2
-
-
6
Mortierella pusilla
-
-
6.5 - 7.5
-
trypsin-activated enzyme
7.5 - 8.5
Apodachlya sp.
-
-
7.5 - 8
assay at
7.5 - 8
assay at; assay at
8.5
-
10 mM Tris/HCl buffer
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
5.5 - 8
-
pH 5.5: 40% of maximal activity, pH 8.0: 95% of maximal activity
6.5 - 8.5
-
pH 6.5: about 85% of maximal activity, pH 8.5: about 70% of maximal activity
7.1 - 8.3
-
50% of maximal activity at pH 7.1 and pH 8.3
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
40
-
chitin synthase 2
42 - 46
Apodachlya sp.
-
-
TEMPERATURE RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
9 - 43
-
50% of maximal activity at 9°C and at 43°C
17.5 - 41
-
50% of maximal activity at 17.5°C and at 41°C
20 - 40
-
20°C: about 80% of maximal activity, 40°C: about 55% of maximal activity
21 - 30
-
21°C: 50% of maximal activity, 30°C: optimum
25 - 50
-
25°C: about 60% of maximal activity, 50°C: about 90% of maximal activity, chitin synthase 1
27 - 42
-
50% of maximal activity at 17°C and at 42°C
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
CHS5 is localized at the growing bud and hyphal tips, indicating that they participate in tip growth
Manually annotated by BRENDA team
class A CHS
Manually annotated by BRENDA team
-
substantial amounts of CHS-1 and CHS-2 RNA are present 4 to 8 hours after induction of cyst formation by glucose deprivation. In contrast to CHS-1 RNA, expression of CHS-2 RNA is more transient and no plateau is observed between 8 and 16 hours of encystation. Both CHS RNAs are no longer detectable after 48 hours when most of the cells are transformed into mature cysts
Manually annotated by BRENDA team
-
synthesis of chitin continues to take place in nematode eggs within the egg sac in the parasitic nematode. The removal of the activity affects egg development
Manually annotated by BRENDA team
early embryos contain large amounts of Bm-chs-1 transcripts, later stage embryos within the maternal uterus show little or no Bm-chs-1 transcripts
Manually annotated by BRENDA team
Lucilia sp.
-
underlying the procuticle
Manually annotated by BRENDA team
isoform IIIb appears to be involved exclusively in cell wall construction during haustorium development
Manually annotated by BRENDA team
BmChsA gene in the epidermis of the head
Manually annotated by BRENDA team
strong expression
Manually annotated by BRENDA team
CHS5 is localized at the growing bud and hyphal tips, indicating that they participate in tip growth; CHS6 is localized at the growing bud and hyphal tips, indicating that they participate in tip growth; CHS7 is localized at the growing bud and hyphal tips, indicating that they participate in tip growth
Manually annotated by BRENDA team
Chlorovirus CVK2
-
the chitin synthase gene from chlorovirus CVK2 is expressed 10 min postinfection in Chlorella cells
Manually annotated by BRENDA team
-
enzyme predominantly localizes at polarized growth sites and between vesicles and metulae, between metulae and phialides, and between phalides and conidia in asexual development
Manually annotated by BRENDA team
-
enzyme predominantly localizes at polarized growth sites and between vesicles and metulae, between metulae and phialides, and between phalides and conidia in asexual development
Manually annotated by BRENDA team
additional information
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
-
CsmA tagged with 9*HA epitopes is localized near actin structures at the hyphal tips and septation sites. Its myosin motor-like domain is able to bind to actin. Interaction between the myosin motor-like domain and actin is not only necessary for the proper localization of CsmA, but also for CsmA function
Manually annotated by BRENDA team
-
the enzyme is restricted to the apical tips of microvilli from columnar cells
Manually annotated by BRENDA team
additional information
PDB
SCOP
CATH
ORGANISM
UNIPROT
Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
13500
x * 21500, recombinant transmembrane segment ArCS1_E22, x * 13500, recombinant transmembrane segment ArCS1_E22, SDS-PAGE
21500
x * 21500, recombinant transmembrane segment ArCS1_E22, x * 13500, recombinant transmembrane segment ArCS1_E22, SDS-PAGE
30000
-
x * 30000, SDS-PAGE
40000 - 66000
purified recombinant enzyme, gel filtration
52000
-
PAGE
60000
-
x * 174500, calculated, x * 190000 + x * 119000 + x * 60000, SDS-PAGE
67000
-
x * 67000, reversible aggregation into large multimolecular units, SDS-PAGE
102000
x * 102000, calculated
114000
119000
-
x * 174500, calculated, x * 190000 + x * 119000 + x * 60000, SDS-PAGE
123884
x * 123884, sequence calculation
136800
x * 136800, calculated
172000
x * 172000, about, full-length enzyme, sequence calculation
174000
x * 174000, calculated
174500
-
x * 174500, calculated, x * 190000 + x * 119000 + x * 60000, SDS-PAGE
174600
x * 174600, about, sequence calculation
178600
-
-
180700
-
-
190000
-
x * 174500, calculated, x * 190000 + x * 119000 + x * 60000, SDS-PAGE
206900
x * 206900, calculated
210000
x * 210000, SDS-PAGE
440000 - 670000
-
gel filtration
520000
-
gel filtration
540000
-
calculation from sedimentation data
570000
-
gel filtration, calculation from sedimentation coefficient
700000
-
gel filtration
additional information
size analysis of proteins purified at pH 4.7, pH 6.5, and pH 7.5 by using gel filtration, native PAGE, and dynamic light scattering
SUBUNITS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
oligomer
-
x * 174500, calculated, x * 190000 + x * 119000 + x * 60000, SDS-PAGE
polymer
additional information
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
glycoprotein
phosphoprotein
proteolytic modification
side-chain modification
-
prenylation of CSIII components is involved in proper subcellular localization of the enzyme, overview
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
25
-
2 h, solubilized preparations retain 80% of its activity
37
-
cell-free enzyme extract, pH 7.5, stable for over 60 min
40 - 50
-
5 min, 20-25% loss of activity
60
-
5 min, complete loss of activity
95
-
cell-free enzyme extract, pH 7.5, 10 min, inactivation
additional information
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
dithithreitol is required to prevent melanization of the enzyme extract
-
enzyme is very sensitive to proteolytic degradation
high sensitivity of chitosomal chitin synthase 2 to high centrifugal forces
-
the zymogen is highly stable
-
treatment with digitonin causes an increase in specific activity and stability
-
upon lyophilization, about 70% of the activity is recovered
-
wild-type isozyme Chs2 has a half-life of 25 min
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-20°C, solubilized preparations show no loss of activity after 5 weeks
-
-80°C, 20% glycerol, stable
-
-80°C, digitonin-solubilized enzyme is stable for several months, purified enzyme is stable for at least a few weeks
-
-80°C, quite stable for several months
-
4°C, 20% glycerol, 50% loss of activity after several days
-
Purification/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
partial
partial purification of recombinant Chs2 from Pichia pastoris membranes by nickel affinity chromatography
recombinant His-tagged enzyme fragment by nickel affinity chromatography
recombinant His-tagged transmembrane protein ArCS1_E22TM from Dictyostelium discoideum by nickel affinity chromatography, soluble recombinant ArCS1_E22 proteins can be purified as monomers only at basic pH of 9.0
Cloned/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
; functional expression in Pichia pastoris
chitin synthase 2
-
cloning and expression of class I CHS isozyme; cloning and expression of class III CHS isozyme; cloning and expression of class IV and V CHS isozymes
cloning from anterior midguts of fifth instar larvae, expression in Saccharomyces cerevisiae AH109 cells and protein interaction analysis by yeast two hybrid screening, identifying a chymotrypsin-like protease CTLP1 that binds to the extracellular carboxyterminal domain of CHS2
comparative sequence analysis, cloning and expression of the enzyme's transmembrane segment ArCS1_E22TM, recombinant expression of the His-tagged domain in Dictyostelium discoideum, the corresponding transmembrane protein ArCS1_E22TM accumulates in membrane fractions of the expression host Dictyostelium discoideum, recombinant expression of clone EIIIab containing the ArCS1_E22 cDNA fragment in Escherichia coli strain BL21(DE3)
expressed in Saccharomyces cerevisiae using the GAL1 promoter in a multicopy plasmid
-
expression in CF203/2.5 insect cell
expression in Escherichia coli
expression of a 12 kDa Myo12p epitope located in the C-terminal end of the N-terminal myosin motorlike domain with a P-loop and use for generation of antibodies
expression of Chs4p-GFP and Chs3p-GFP in CRM233 and CRM103 strains, respectively
-
gene BcChs6, cloning in Escherichia coli strain DH5alpha, Agrobacterium-mediated transformation of Bortrytis cinerea spores for gene disruption
gene BmChsA, semiquantitative RT-PCR expression analysis, expression pattern
gene BmChsB, DNA and amino acid sequence determination and analysis, seqeunce comparisons, quantitative expression analysis and expression profile
gene chs-3, DNA and amino acid sequence determination and analysis, expression of GFP-labeled CHS-3 in hyphae and subcellular localization, overview; gene chs-6, DNA and amino acid sequence determination and analysis, expression of GFP-labeled CHS-6 in hyphae and subcellular localization, overview
gene CHS1, expression of YFP-tagged wild-type and mutant isozymes in strain BWP17, location of the YFP-tagged Chs proteins in yeast and hyphal cells, overview; gene CHS2, expression of YFP-tagged wild-type and mutant isozymes in strain BWP17, location of the YFP-tagged Chs proteins in yeast and hyphal cells, overview; gene CHS3, expression of YFP-tagged wild-type and mutant isozymes in strain BWP17, location of the YFP-tagged Chs proteins in yeast and hyphal cells, overview; gene CHS8, expression of YFP-tagged wild-type and mutant isozymes in strain BWP17, location of the YFP-tagged Chs proteins in yeast and hyphal cells, overview
P23316, P30572, P30573, Q5A7T2
gene chs2, DNA and amino acid sequence determination and analysis; gene chs2, DNA and amino acid sequence determination and analysis
gene CHSA, DNA and amino acid sequence determination and analysis, phylogenetic analysis, expression of a fragment comprising base pairs 2040-2495 as His-tagged protein
gene CHSA, expression analysis
gene CHSB, DNA and amino acid sequence determination and analysis, genetic structure,phylogenetic analysis, expression analysis, sequence comparisons
gene chsVII, phylogenetic analysis, quantitative RT-PCR enzyme expression analyis
gene Lechs1, DNA and amino acid sequence determination and analysis, phylogenetic analysis, genetic structure, expression in Escherichia coli strain JM109
gene Pochs1, DNA and amino acid sequence determination and analysis, sequence comparisons, quantitative expression analysis
-
genes CHS1-4, phylogenetic tree, expression of deeltion mutants, quantitative expression analysis by RT-PCR
-
high level expression of wild-type Chs2 and a mutant Chs2DELTAN222 lacking the N-terminal region in Escherichia coli strain C41 and in Pichia pastoris strain SMD1163 membranes in an active form, the latter system results in higher enzyme activity, overview
myosin motor-like chitin synthase gene chsVb, DNA and amino acid sequence determination and analysis, expression analysis, phylogenetic tree and analysis
overexpression in Saccharomyces cerevisiae
-
overexpression of CHS2p isozyme in Saccharomyces cerevisiae strains; overexpression of CHS isozymes in Saccharomyces cerevisiae strains
-
since chitin synthase 2 can not expressed in bacterial cells or insect cells in an active form, Saccharomyces cerevisiae is used as the host for overexpression
-
the entire region of csmB cDNA is cloned by 5' and 3' RACE methods
WdChs5p-myc protein has a differential expression feature that is similar to the differential transcription of the WdCHS5 gene, transcriptional regulation is the first and probably the most important control point of the expression ofWdCHS5, overview, expression of wild-type and myc-tagged enzyme in Escherichia coli strain DH5alpha, expression of WdChs5p-myc protein in Wangiella dermatitidis, expression patterns, overview
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
CHS7 transcription is strongly induced on germination of spores, and a tagged Chs7 protein is produced abundantly during infection-related morphogenesis
decrease in transcription under higher osmotic conditions, e.g., in the presence of 0.3 M KCl; decrease in transcription under higher osmotic conditions, e.g., in the presence of 0.3 M KCl; low glucose concentrations of 0.05% instead of 3% provoke a derepression of transcription. Oxidative stress due to mycelial growth in presence of 5 mM H2O2, induces higher transcription levels; low glucose concentrations of 0.05% instead of3% provoke a derepression of transcription. Oxidative stress due to mycelial growth in presence of 5 mM H2O2, induces higher transcription levels
exogenous 20-hydroxyecdysone and methoprene, a juvenile hormone analogue, significantly upregulate the expression of BmChsB when the levels of endogenous molting hormone are low and the levels of endogenous juvenile hormone are high immediately after molting. When levels of endogenous molting hormone are high and those of endogenous juvenile hormone are low during the molting stage, exogenous 20-hydroxyecdyson does not upregulate BmChsB expression and exogenous methoprene upregulates it negligibly. When the endogenous hormone levels are low during the mulberry-leaf intake process, BmChsB expression is upregulated by exogenous methoprene
exogenous hormones, 20-hydroxyecdysone and methoprene, significantly upregulate the expression of gene BmChsA at low levels of endogenous molting hormone and high levels of endogenous juvenile hormone immediately after molting. With low levels of endogenous hormones during the mulberry intake process, BmChsA is rarely upregulated by exogenous hormones. With high levels of endogenous molting hormone and low levels of endogenous juvenile hormone during the molting stage, upregulation of gene BmChsA by exogenous hormones is not detected
nikkomycin Z, a chitin synthase inhibitor, downregulates the expression of BmChsA and decreases the amount of epidermis chitin during the molting process
presence of alternative exons CHSA-2a and CHSA-2b. Transcripts of both exons are preferentially expressed in epidermis. During growth and development of Ostrinia furnacalis, CHSA-2a is mainly expressed during larval-larval molting and larval-pupal transformation, as well as in newly-laid eggs, while CHSA-2b is expressed only during the larval-larval molting
the transcription level is relatively constant at the 4th instar stage but decreases between the 4th and the 5th instar molting time, with gradually increase throughout the 5th instar. Transcription level drops dramatically when the feeding ceases at the 6th day of the 5th instar. At the larval-pupal molting time, only minor amounts of transcripts can be detected. During the pupal stages, the transcription level increases at the 3rd day and then drops at the 4th day, suggesting that the enzyme might be involved in tissue reconstruction during the pupa-adult metamorphosis
treatment of Candida albicans with low levels of echinocandins such as caspofungin, echinocandin B, cilofungin and anidulafungin stimulates chitin synthase gene expression, increases Chs activity, elevates chitin content and reduced efficacy of these drugs
-
ENGINEERING
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
D562A
-
almost complete loss of activity
E561A
-
almost complete loss of activity
Q601A
-
almost complete loss of activity
R563A
-
almost complete loss of activity
R602A
-
almost complete loss of activity
R603A
-
almost complete loss of activity
R604A
-
almost complete loss of activity
V377I
-
enhanced emzymic activity in vitro. Mutation suppresses mutations in the C2 domain of INN1 protein, which is required for ingression
W605A
-
almost complete loss of activity
Y521A
-
almost complete loss of activity
additional information
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
agriculture
analysis
the chs3 gene encoding the chitin synthase 3 is used for synthetically lethality screening for mutation determination, overview
Show AA Sequence (294 entries)
Please use the Sequence Search for a specific query.